U.S. Estimates of Pediatric Spinal Cord Injury: Implications for Clinical Care and Research Planning

Jaspreet K Dhillon1, Junxin Shi2, Alyssa Janezic2

  • 11 The Ohio State University College of Medicine , Columbus, Ohio.

Journal of Neurotrauma
|December 31, 2016
PubMed

Insights

Accurate estimates show that only a small fraction of children with spinal cord injuries (SCIs) meet clinical trial criteria. These eligible pediatric SCI patients are concentrated in the South, often treated at non-pediatric centers.

Area of Science:

  • Pediatric Traumatology
  • Epidemiology of Spinal Cord Injury
  • Clinical Trial Eligibility

Background:

  • Spinal cord injuries (SCIs) in children are a significant public health concern.
  • Characterizing the pediatric SCI population is crucial for advancing research and clinical care.
  • Identifying children eligible for clinical trials is essential for therapeutic development.

Purpose of the Study:

  • To provide accurate national estimates of children with spinal cord injuries (SCIs).
  • To identify and characterize the subset of pediatric SCI patients eligible for clinical trials.
  • To inform resource allocation for pediatric SCI research and care.

Main Methods:

  • Utilized the Kids' Inpatient Database (2006, 2009, 2012) to identify children (<18 years) with SCI International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes.
  • Applied exclusion criteria (late effects, transfers, unspecified levels, short stays) to refine the SCI cohort.
  • Employed conventional rationale to determine clinical trial eligibility for pediatric SCI cases.

Main Results:

  • Over three years, 2,484 children had SCI ICD-9-CM codes; 1,342 had true SCI, and 706 met clinical trial criteria.
  • National estimates indicate 2,013 children with SCI and 1,062 eligible for trials.
  • Eligible pediatric SCI patients were predominantly in the cervical region (66.1%), male (65.5%), older (51.1% aged 16-17), and located in the South (49.8%).
  • Most were treated at urban teaching hospitals (84.6%), with only 20.3% at pediatric centers; 66.3% of hospitals treated only one child with SCI over three years.

Conclusions:

  • Children eligible for SCI clinical trials represent less than one-third of those with SCI ICD-9-CM codes.
  • These children are regionally concentrated and infrequently treated at specialized pediatric centers.
  • Findings underscore the need for strategic resource allocation to optimize pediatric SCI clinical care and research outcomes.